AVXL
Price
$10.87
Change
-$0.31 (-2.77%)
Updated
Dec 24 closing price
43 days until earnings call
TRAW
Price
$11.61
Change
-$0.96 (-7.64%)
Updated
Dec 24 closing price
Ad is loading...

AVXL vs TRAW

Header iconAVXL vs TRAW Comparison
Open Charts AVXL vs TRAWBanner chart's image
Anavex Life Sciences
Price$10.87
Change-$0.31 (-2.77%)
Volume$2.88M
CapitalizationN/A
Traws Pharma
Price$11.61
Change-$0.96 (-7.64%)
Volume$666.8K
CapitalizationN/A
AVXL vs TRAW Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. TRAW commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and TRAW is a Hold.

COMPARISON
Comparison
Dec 25, 2024
Stock price -- (AVXL: $10.87 vs. TRAW: $11.61)
Brand notoriety: AVXL and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 173% vs. TRAW: 104%
Market capitalization -- AVXL: $921.94M vs. TRAW: $35.13M
AVXL [@Biotechnology] is valued at $921.94M. TRAW’s [@Biotechnology] market capitalization is $35.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 0 green, 5 red.
According to our system of comparison, TRAW is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 3 TA indicator(s) are bullish while TRAW’s TA Score has 6 bullish TA indicator(s).

  • AVXL’s TA Score: 3 bullish, 4 bearish.
  • TRAW’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than AVXL.

Price Growth

AVXL (@Biotechnology) experienced а +18.02% price change this week, while TRAW (@Biotechnology) price change was +128.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.88%. For the same industry, the average monthly price growth was -1.84%, and the average quarterly price growth was +2.99%.

Reported Earning Dates

AVXL is expected to report earnings on Feb 06, 2025.

TRAW is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-0.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($922M) has a higher market cap than TRAW($35.1M). AVXL YTD gains are higher at: 16.756 vs. TRAW (-37.715). AVXL has more cash in the bank: 21.2M vs. TRAW (5.41M).
AVXLTRAWAVXL / TRAW
Capitalization922M35.1M2,627%
EBITDAN/A-24.08M-
Gain YTD16.756-37.715-44%
P/E RatioN/AN/A-
RevenueN/A226K-
Total Cash21.2M5.41M392%
Total Debt88.2KN/A-
FUNDAMENTALS RATINGS
AVXL vs TRAW: Fundamental Ratings
AVXL
TRAW
OUTLOOK RATING
1..100
1533
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (39) in the Biotechnology industry is in the same range as AVXL (62). This means that TRAW’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (65) in the Biotechnology industry is somewhat better than the same rating for TRAW (100). This means that AVXL’s stock grew somewhat faster than TRAW’s over the last 12 months.

AVXL's SMR Rating (96) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

AVXL's Price Growth Rating (35) in the Biotechnology industry is in the same range as TRAW (35). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

AVXL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as TRAW (100). This means that AVXL’s stock grew similarly to TRAW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLTRAW
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA462.2831.68
+7.36%
Tesla
BTC.X98676.0900003989.851600
+4.21%
Bitcoin cryptocurrency
AAPL258.202.93
+1.15%
Apple
SPY601.306.61
+1.11%
SPDR® S&P 500® ETF Trust
GME31.140.24
+0.78%
GameStop Corp

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with CORT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then CORT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-2.77%
CORT - AVXL
53%
Loosely correlated
+2.50%
NTLA - AVXL
45%
Loosely correlated
-0.41%
TENX - AVXL
45%
Loosely correlated
+2.91%
PLRX - AVXL
41%
Loosely correlated
+1.12%
DNLI - AVXL
40%
Loosely correlated
+0.67%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with SLGL. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then SLGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-7.64%
SLGL - TRAW
63%
Loosely correlated
-40.62%
AVXL - TRAW
35%
Loosely correlated
-2.77%
RAPT - TRAW
34%
Loosely correlated
-0.57%
GLTO - TRAW
26%
Poorly correlated
+2.95%
GTBP - TRAW
26%
Poorly correlated
+13.88%
More